At the same time, several reports indicate altered immunoproteasome subunit expression following treatment of cancer cells with other types of anti-cancer drugs - protein kinase inhibitors that are currently widely used in clinical practice (Burov et al., 2021; Takahashi et al., 2021). This evidence concerns the gene WEE1 and cancer.